Intellia Therapeutics | 8-K: Current report
Intellia Therapeutics | 8-K: Current report
Intellia Therapeutics | 8-K: Current report
Intellia Therapeutics | 8-K: Intellia Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
Intellia Therapeutics | DEFA14A: Others
Intellia Therapeutics | DEF 14A: Definitive information statements
Intellia Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Intellia Therapeutics | 8-K: Current report
Intellia Therapeutics | 8-K: Current report
Intellia Therapeutics | 8-K: Current report
Intellia Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Intellia Therapeutics | 8-K: Intellia Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Company Progress
Intellia Therapeutics | 8-K: Current report
Intellia Therapeutics | 8-K: Current report
Intellia Therapeutics | 8-K: Current report
Intellia Therapeutics | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Intellia Therapeutics | 8-K: Intellia Therapeutics Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress
Intellia Therapeutics | 8-K: Current report
Intellia Therapeutics | 8-K: Current report
Intellia Therapeutics | 8-K: Current report
No Data